OPTIMIZING FERTILITY OUTCOMES: THE SYNERGISTIC ROLE OF GONADOTROPIN-RELEASING HORMONE AGONIST AND DIENOGEST IN ADENOMYOSIS MANAGEMENT DURING FET CYCLES IN IVF/ICSI – A RETROSPECTIVE COHORT STUDY

In: Fertility and Sterility · 2025 · vol. 124(6) , pp. e292 · doi:10.1016/j.fertnstert.2025.07.920 · W4416974223
article OA: closed CC0
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View at publisher → View on OpenAlex
AI-generated summary by gemini-2.5-flash-lite, 2026-07-15

This study investigated the combined effect of GnRH agonist and dienogest on fertility outcomes in women with adenomyosis undergoing frozen embryo transfer cycles in IVF/ICSI.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

adenomyosis

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2025) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

openalex
last seen: 2026-06-04T00:00:01.174412+00:00
License: CC0 · commercial use OK